急诊MRSA鼻拭子PCR对肺炎万古霉素与利奈唑胺疗程的影响
该研究为单中心准实验非等效对照研究,纳入急诊疑诊肺炎并接受抗MRSA治疗且后续入院的成人患者,比较药师驱动MRSA鼻拭子PCR送检策略实施前后抗MRSA治疗时长。结果显示抗MRSA治疗中位时长由干预前5.90小时降至干预后1.13小时(p=0.006),MRSA鼻拭子PCR送检率由69.4%升至86.3%(p=0.18),住院中位天数5.0天对6.0天无显著差异(p=0.10)。结论认为药师参与急诊抗菌药物管理可显著缩短抗MRSA治疗时长,且未对30天再入院率和30天全因死亡率产生不良影响。
要点
- 急诊疑诊肺炎并接受抗MRSA治疗且随后入院的成人患者,药师按既有院内方案驱动MRSA鼻拭子PCR送检后,抗MRSA治疗中位时长由5.90小时降至1.13小时(p=0.006)。
- MRSA鼻拭子PCR送检率由干预前69.4%升至干预后86.3%(p=0.18),组间差异未达统计学显著。
- 住院中位天数干预前5.0天对干预后6.0天,差异无统计学显著(p=0.10)。
- 作者结论认为药师驱动的急诊MRSA鼻拭子PCR送检显著缩短抗MRSA治疗时长,且未对30天再入院率或30天全因死亡率产生不良影响。
适用人群与场景
- 急诊疑诊肺炎、在急诊接受抗MRSA治疗并随后入院的成人患者。
处置流程与药物剂量
- 急诊药师按既有院内方案负责开具MRSA鼻拭子PCR医嘱,急诊护士协助在急诊完成鼻拭子采集。
- 干预后组(药师驱动送检策略实施后)抗MRSA治疗中位时长为1.13小时,干预前组为5.90小时。
研究设计与关键结果
- 研究类型为单中心准实验非等效对照研究,使用电子健康记录数据,共纳入200例成人急诊疑诊肺炎、接受抗MRSA治疗并随后入院的患者。
- 抗MRSA治疗中位时长干预前组5.90小时对干预后组1.13小时(p=0.006)。
- MRSA鼻拭子PCR送检率干预前69.4%对干预后86.3%(p=0.18)。
- 住院中位天数干预前组5.0天对干预后组6.0天,差异无统计学显著(p=0.10)。
证据类型、等级与局限
- 证据类型:单中心准实验非等效对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急诊疑诊肺炎并启动抗MRSA治疗的成人患者中,由药师按既有院内方案驱动MRSA鼻拭子PCR送检,可缩短抗MRSA治疗时长。
- 作者认为药师参与急诊抗菌药物管理具有价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of nosocomial pneumonia, often prompting empiric anti-MRSA therapy despite low prevalence in emergency department (ED) presentations. MRSA nasal polymerase chain reaction (PCR) offers a rapid, non-invasive method to guide de-escalation of MRSA-targeted therapy. This study aims to evaluate the impact of pharmacist-driven MRSA nasal PCR ordering in the ED on the duration of anti-MRSA therapy.
METHODS: We conducted a quasi-experimental non-equivalent control study at a single academic center using data from an electronic health record. Adult ED patients with suspected pneumonia who received anti-MRSA therapy in the ED and were subsequently admitted were included. Emergency department pharmacists were responsible for ordering MRSA nasal PCR in compliance with a pre-existing hospital protocol. ED nurses facilitated MRSA nasal PCR collection in the ED.
RESULTS: A total of 200 patients were included in the final analysis. The median duration of anti-MRSA therapy was 5.90 h and 1.13 h for pre- and post-intervention groups, respectively (p = 0.006). Incidence of MRSA nasal PCRs ordered increased from 69.4% pre-intervention to 86.3% post-intervention (p = 0.18). Median length of hospital stay was not significantly different between groups (5.0 days vs. 6.0 days, p = 0.10).
CONCLUSIONS: Pharmacist-driven MRSA nasal PCR ordering in the ED significantly reduced anti-MRSA therapy duration without adversely affecting 30-day readmission rates or all-cause 30-day mortality. These findings highlight the value of pharmacist engagement in antibiotic stewardship in the ED.
参考来源
- Am J Emerg Med:Impact of MRSA nasal PCR in the emergency department on duration of vancomycin and linezolid for pneumonia
- Skaar SM, Wex N, Wehling H, et al. Impact of MRSA nasal PCR in the emergency department on duration of vancomycin and linezolid for pneumonia. Am J Emerg Med. 2026. PMID: 42994388. doi:10.1016/j.ajem.2026.10.016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。